2,169
Views
24
CrossRef citations to date
0
Altmetric
Review Article

Efficacy and safety of US-guided thermal ablation for primary hyperparathyroidism: a systematic review and meta-analysis

, , , , , , & show all
Pages 245-253 | Received 30 Nov 2019, Accepted 18 Feb 2020, Published online: 05 Mar 2020

References

  • Bilezikian JP, Bandeira L, Khan A, et al. Hyperparathyroidism. Lancet. 2018;391(10116):168–178.
  • Machado NN, Wilhelm SM. Diagnosis and evaluation of primary hyperparathyroidism. Surg Clin North Am. 2019;99(4):649–666.
  • Minisola S, Gianotti L, Bhadada S, et al. Classical complications of primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab. 2018;32(6):791–803.
  • Walker MD, Silverberg SJ. Cardiovascular aspects of primary hyperparathyroidism. J Endocrinol Invest. 2008;31(10):925–931.
  • Lind L, Hvarfner A, Palmer M, et al. Hypertension in primary hyperparathyroidism in relation to histopathology. Eur J Surg. 1991;157(8):457–459.
  • Vestergaard P. Primary hyperparathyroidism and nephrolithiasis. Ann Endocrinol (Paris). 2015;76(2):116–119.
  • Peacock M. Primary hyperparathyroidism and the kidney: biochemical and clinical spectrum. J Bone Miner Res. 2002;17 (Suppl 2):N87–94.
  • Mazzuoli GF, D’Erasmo E, Pisani D. Primary hyperparathyroidism and osteoporosis. Aging Clin Exp Res). 1998;10(3):225–231.
  • Makras P, Anastasilakis AD. Bone disease in primary hyperparathyroidism. Metabolism. 2018;80:57–65.
  • Ejlsmark-Svensson H, Bislev LS, Lajlev S, et al. Prevalence and risk of vertebral fractures in primary hyperparathyroidism: a nested case-control study. J Bone Miner Res. 2018;33(9):1657–1664.
  • Misiorowski W, Czajka-Oraniec I, Kochman M, et al. Osteitis fibrosa cystica-a forgotten radiological feature of primary hyperparathyroidism. Endocrine. 2017;58(2):380–385.
  • Nilsson IL. Primary hyperparathyroidism: should surgery be performed on all patients? Current evidence and residual uncertainties. J Intern Med. 2019;285(2):149–164.
  • Egan RJ, Scott-Coombes DM. The surgical management of sporadic primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab. 2018;32(6):847–859.
  • Strom C, Rasmussen LS, Sieber FE. Should general anaesthesia be avoided in the elderly? Anaesthesia. 2014;69 (Suppl 1):35–44.
  • Katz SC, Wang GJ, Kramer EL, et al. Limitations of technetium 99m sestamibi scintigraphic localization for primary hyperparathyroidism associated with multiglandular disease. Am Surg. 2003;69(2):170–175.
  • Head HW, Dodd GD, III. Thermal ablation for hepatocellular carcinoma. Gastroenterology. 2004;127(5):S167–S78.
  • Ben Hamou A, Ghanassia E, Espiard S, et al. Safety and efficacy of thermal ablation (radiofrequency and laser): should we treat all types of thyroid nodules? Int J Hyperthermia. 2019;36(1):666–676.
  • Sanchez A, Feldman AS, Hakimi AA. Current management of small renal masses, including patient selection, renal tumor biopsy, active surveillance, and thermal ablation. JCO. 2018;36(36):3591–3600.
  • Dobnig H, Amrein K. Value of monopolar and bipolar radiofrequency ablation for the treatment of benign thyroid nodules. Best Pract Res Clin Endocrinol Metab. 2019;33(4):1–15.
  • Ruiter SJS, Heerink WJ, de Jong KP. Liver microwave ablation: a systematic review of various FDA-approved systems. Eur Radiol. 2019;29(8):4026–4035.
  • de Senneville BD, Moonen C, Ries M. MRI-guided HIFU methods for the ablation of liver and renal cancers. Adv Exp Med Biol. 2016;880:43–63.
  • Ha EJ, Baek JH, Kim KW, et al. Comparative efficacy of radiofrequency and laser ablation for the treatment of benign thyroid nodules: systematic review including traditional pooling and bayesian network meta-analysis. J Clin Endocrinol Metab. 2015;100(5):1903–1911.
  • Feng B, Liang P. Local thermal ablation of renal cell carcinoma. Eur J Radiol. 2012;81(3):437–440.
  • Bennedbaek FN, Karstrup S, Hegedüs L. Ultrasound guided laser ablation of a parathyroid adenoma. BJR. 2001;74(886):905–907.
  • Andrioli M, Riganti F, Pacella CM, et al. Long-term effectiveness of ultrasound-guided laser ablation of hyperfunctioning parathyroid adenomas: present and future perspectives. Am J Roentgenol. 2012;199(5):1164–1168.
  • Jiang TA, Chen F, Zhou X, et al. Percutaneous ultrasound-guided laser ablation with contrast-enhanced ultrasonography for hyperfunctioning parathyroid adenoma: a preliminary case series. Int J Endocrinol. 2015;2015:1–6.
  • Liu C, Wu B, Huang PT, et al. US-guided percutaneous microwave ablation for primary hyperparathyroidism with parathyroid nodules: feasibility and safety study. J Vasc Intervent Radiol. 2016;27(6):867–875.
  • Yu MA, Yao L, Zhang L, et al. Safety and efficiency of microwave ablation for recurrent and persistent secondary hyperparathyroidism after parathyroidectomy: a retrospective pilot study. Int J Hyperthermia. 2016;32(2):180–186.
  • Sormaz IC, Poyanli A, Acar S, et al. CASE SERIES The Results of Ultrasonography-Guided Percutaneous Radiofrequency Ablation in Hyperparathyroid Patients in Whom Surgery Is Not Feasible. Cardiovasc Intervent Radiol. 2017;40(4):596–602.
  • Wang G, Liu S, Liu X, et al. Microwave ablation: an effective treatment for mild-to-moderate secondary hyperparathyroidism in patients undergoing haemodialysis. Int J Hyperthermia. 2017;33(8):946–952.
  • Zhuo L, Peng LL, Zhang YM, et al. US-guided microwave ablation of hyperplastic parathyroid glands: safety and efficacy in patients with end-stage renal disease-a pilot study. Radiology. 2017;282(2):576–584.
  • Knobloch K, Yoon U, Vogt PM. Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias. J Craniomaxillofac Surg. 2011;39(2):91–92.
  • Sacks D, McClenny TE, Cardella JF, et al. Society of Interventional Radiology clinical practice guidelines. J Vasc Intervent Radiol. 2003;14(9):S199–S202.
  • Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383–394.
  • Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988. p. 1–17.
  • Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560.
  • Zwahlen M, Renehan A, Egger M. Meta-analysis in medical research: potentials and limitations. Urol Oncol. 2008;26(3):320–329.
  • Borenstein M, Hedges LV, Higgins JP, et al. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Method. 2010;1(2):97–111.
  • Copas J, Shi JQ. Meta-analysis, funnel plots and sensitivity analysis. Biostatistics. 2000;1(3):247–262.
  • Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
  • Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Statist Med. 2006;25(20):3443–3457.
  • Kovatcheva R, Vlahov J, Stoinov J, et al. US-guided high-intensity focused ultrasound as a promising non-invasive method for treatment of primary hyperparathyroidism. Eur Radiol. 2014;24(9):2052–2058.
  • Fan BQ, He XW, Chen HH, et al. US-guided microwave ablation for primary hyperparathyroidism: a safety and efficacy study. Eur Radiol. 2019;29(10):5607–5616.
  • Liu F, Yu X, Liu Z, et al. Comparison of ultrasound-guided percutaneous microwave ablation and parathyroidectomy for primary hyperparathyroidism. Int J Hyperther. 2019;36(1):835–840.
  • Bilezikian JP. Primary Hyperparathyroidism. J Clin Endocrinol Metab. 2018;103(11):3993–4004.
  • Insogna KL. Primary Hyperparathyroidism. N Engl J Med. 2018;379(11):1050–1059.
  • Regier M, Chun F. Thermal ablation of renal tumors: indications, techniques and results. Dtsch Arztebl Int. 2015;112(24):412–418.
  • Vogl TJ, Farshid P, Naguib NN, et al. Thermal ablation of liver metastases from colorectal cancer: radiofrequency, microwave and laser ablation therapies. Radiol Med. 2014;119(7):451–461.
  • Yin XY, Xie XY, Lu MD, et al. Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors. Cancer. 2009;115(9):1914–1923.
  • Trimboli P, Castellana M, Sconfienza LM, et al. Efficacy of thermal ablation in benign non-functioning solid thyroid nodule: a systematic review and meta-analysis. Endocrine. 2020;67(1):35–43.
  • Mauri G, Cova L, Monaco CG, et al. Benign thyroid nodules treatment using percutaneous laser ablation (PLA) and radiofrequency ablation (RFA). Int J Hyperthermia. 2017;33(3):295–299.
  • Chung SR, Suh CH, Baek JH, et al. Safety of radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: a systematic review and meta-analysis. Int J Hyperthermia. 2017;33(8):920–930.
  • Gong L, Tang W, Lu J, et al. Thermal ablation versus parathyroidectomy for secondary hyperparathyroidism: a meta-analysis. Int J Surg. 2019;70:13–18.